AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aquestive Therapeutics, Inc. Director's Dealing 2020

Feb 26, 2020

32552_dirs_2020-02-26_516f9c2b-117e-4c22-b02c-99efe327c935.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2019-12-31

Reporting Person: Kendall Keith J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-31	Common Stock	F	149	$5.82	Disposed	670811	Direct

Footnotes

F1: This amendment is being filed solely to amend the number of withheld shares due to a mistake in the number of shares withheld upon vesting of RSUs as reported in the original Form 4 filed on January 2, 2020.